Cambridge Investment Research Advisors
DIAX

Cambridge Investment Research Advisors’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DIAX Stock Details DIAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,540
Closed -$481K – 3965
2025
Q4 		$481K Sell
31,540
-1,486
-4% -$22.1K ﹤0.01% 2750
2025
Q3 		$492K Sell
33,026
-4,471
-12% -$64.9K ﹤0.01% 2694
2025
Q2 		$538K Sell
37,497
-23,963
-39% -$333K ﹤0.01% 2475
2025
Q1 		$891K Buy
61,460
+13,078
+27% +$197K ﹤0.01% 1954
2024
Q4 		$729K Buy
48,382
+4,902
+11% +$74.3K ﹤0.01% 2117
2024
Q3 		$646K Sell
43,480
-387
-0.9% -$5.55K ﹤0.01% 2206
2024
Q2 		$615K Buy
43,867
+2,808
+7% +$39.4K ﹤0.01% 2125
2024
Q1 		$602K Sell
41,059
-854
-2% -$12.3K ﹤0.01% 2123
2023
Q4 		$587K Buy
41,913
+2,004
+5% +$27.3K ﹤0.01% 2065
2023
Q3 		$547K Sell
39,909
-18,509
-32% -$262K ﹤0.01% 2014
2023
Q2 		$824K Sell
58,418
-40
-0.1% -$580 ﹤0.01% 1742
2023
Q1 		$858K Buy
58,458
+1,042
+2% +$15.8K ﹤0.01% 1674
2022
Q4 		$891K Buy
57,416
+3,442
+6% +$52.2K ﹤0.01% 1593
2022
Q3 		$728K Buy
53,974
+5,227
+11% +$81K ﹤0.01% 1690
2022
Q2 		$745K Buy
48,747
+2,446
+5% +$39.1K ﹤0.01% 1674
2022
Q1 		$769K Buy
46,301
+4,210
+10% +$70.5K ﹤0.01% 1774
2021
Q4 		$748K Sell
42,091
-1,310
-3% -$22.9K ﹤0.01% 1778
2021
Q3 		$727K Buy
43,401
+321
+0.7% +$5.54K ﹤0.01% 1771
2021
Q2 		$733K Buy
43,080
+7,980
+23% +$134K ﹤0.01% 1772
2021
Q1 		$570K Sell
35,100
-284
-0.8% -$4.36K ﹤0.01% 1809
2020
Q4 		$538K Buy
35,384
+179
+0.5% +$2.56K ﹤0.01% 1724
2020
Q3 		$476K Buy
35,205
+2,513
+8% +$34.7K ﹤0.01% 1633
2020
Q2 		$445K Buy
32,692
+294
+0.9% +$3.92K ﹤0.01% 1625
2020
Q1 		$406K Sell
32,398
-991
-3% -$15.9K ﹤0.01% 1500
2019
Q4 		$590K Buy
33,389
+267
+0.8% +$4.75K ﹤0.01% 1477
2019
Q3 		$590K Sell
33,122
-1,906
-5% -$33.6K 0.01% 1388
2019
Q2 		$617K Sell
35,028
-1,413
-4% -$24.9K 0.01% 1303
2019
Q1 		$656K Buy
36,441
+4,332
+13% +$76.3K 0.01% 1302
2018
Q4 		$518K Buy
32,109
+207
+0.6% +$3.7K 0.01% 1297
2018
Q3 		$631K Sell
31,902
-2,292
-7% -$43.9K 0.01% 1313
2018
Q2 		$632K Sell
34,194
-2,008
-6% -$37.8K 0.01% 1276
2018
Q1 		$643K Buy
36,202
+3,453
+11% +$63.4K 0.01% 1197
2017
Q4 		$617K Buy
32,749
+7,474
+30% +$133K 0.01% 1198
2017
Q3 		$429K Buy
25,275
+8
+0% +$133 0.01% 1332
2017
Q2 		$417K Buy
25,267
+8
+0% +$129 0.01% 1302
2017
Q1 		$395K Buy
25,259
+332
+1% +$5.2K 0.01% 1200
2016
Q4 		$374K Sell
24,927
-1,747
-7% -$25.4K 0.01% 1163
2016
Q3 		$385K Buy
26,674
+1,610
+6% +$23.6K 0.01% 1169
2016
Q2 		$364K Sell
25,064
-769
-3% -$10.9K 0.01% 1096
2016
Q1 		$364K Sell
25,833
-1,332
-5% -$17.9K 0.01% 1067
2015
Q4 		$390K Sell
27,165
-1,146
-4% -$16.3K 0.01% 991
2015
Q3 		$382K Buy
+28,311
New +$406K 0.01% 904

Other funds holding DIAX

SC
Stolper & Co Tulsa, Oklahoma $387M AUM 25.53% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return

Cambridge Investment Research Advisors's DIAX Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 31,540 shares — an estimated $481K sold.

Cambridge Investment Research Advisors first reported a position in DIAX in Q3 2015 and held it in 42 quarters. The position peaked at $891K in Q1 2025. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 31,540 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $481K.
  • Cambridge Investment Research Advisors first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q3 2015 and held it in 42 quarters.
  • Cambridge Investment Research Advisors's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $891K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.